Clinical, radiological and laboratory characteristics of central nervous system histoplasmosis: A systematic review of a severe disease

Imagem de Miniatura
Arquivos
art_OLIVEIRA_Clinical_radiological_and_laboratory_characteristics_of_central_nervous_2023.PDF (1.43 MB)
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
Citação
MYCOSES, v.66, n.8, p.659-670, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BackgroundThe knowledge of central nervous system (CNS) histoplasmosis is limited to case reports and series. ObjectivesOur objective was to synthesise clinical, radiological and laboratory characteristics of CNS histoplasmosis to improve our understanding of this rare disease. MethodsWe performed a systematic review using Pubmed/MEDLINE, Embase and LILACS databases accessed on March 2023 without publication date restrictions. Inclusion criteria comprised: (1) histopathological, microbiological, antigen or serological evidence of histoplasmosis; (2) CNS involvement based on cerebrospinal fluid pleocytosis or neuroimaging abnormalities. We classified the certainty of the diagnosis in proven (CNS microbiological and histopathological confirmation), probable (CNS serological and antigen confirmation) or possible (non-CNS evidence of histoplasmosis). Metaproportion was used to provide a summary measure with 95% confidence intervals for the clinical, radiological and laboratory characteristics. Chi-squared test was used to compare mortality between pairs of antifungal drugs. ResultsWe included 108 studies with 298 patients. The median age was 31 years, predominantly male, and only 23% were immunocompromised (134/276, 95%CI: 3-71), mainly due to HIV infection. The most common CNS symptom was headache (130/236, 55%, 95%CI: 49-61), with a duration predominantly of weeks or months. Radiological presentation included histoplasmoma (79/185, 34%, 95%CI: 14-61), meningitis (29/185, 14%, 95%CI: 7-25), hydrocephalus (41/185, 37%, 95%CI: 7-83) and vasculitis (18/185, 6%, 95%CI: 1-22). There were 124 proven cases, 112 probable cases and 40 possible cases. The majority of patients presented positive results in CNS pathology (90%), serology (CSF: 72%; serum: 70%) or CSF antigen (74%). Mortality was high (28%, 56/198), but lower in patients who used liposomal amphotericin B and itraconazole. Relapse occurred in 13% (23/179), particularly in HIV patients, but less frequently in patients who used itraconazole. ConclusionCentral nervous system histoplasmosis usually presents subacute-to-chronic symptoms in young adults. Neuroimaging patterns included not only focal lesions but also hydrocephalus, meningitis and vasculitis. Positive results were commonly found in CSF antigen and serology. Mortality was high, and treatment with liposomal amphotericin B followed by itraconazole may decrease mortality.
Palavras-chave
central nervous system, histoplasmosis, systemic infection
URI
https://observatorio.fm.usp.br/handle/OPI/54693
Referências
  1. Abu Khalaf S, 2022, IDCASES, V27, DOI 10.1016/j.idcr.2021.e01364
  2. Ala-Kauhaluoma M, 2010, ACTA OPHTHALMOL, V88, P493, DOI 10.1111/j.1755-3768.2008.01454.x
  3. Alamri M, 2021, J INFECT PUBLIC HEAL, V14, P1013, DOI 10.1016/j.jiph.2021.05.012
  4. ALLO MD, 1979, J NEUROSURG, V51, P242, DOI 10.3171/jns.1979.51.2.0242
  5. ANAISSIE E, 1988, AM J MED, V84, P215, DOI 10.1016/0002-9343(88)90416-0
  6. [Anonymous], 2017, EUR J NEUROL, V24, P123, DOI [10.1111/ene.13367, DOI 10.1111/ENE.13367]
  7. [Anonymous], 2012, NEUROCRIT CARE, V17, P1, DOI [10.1007/s12028-012-9775-0, DOI 10.1007/S12028-012-9775-0]
  8. Ashraf N, 2020, MYCOPATHOLOGIA, V185, P843, DOI 10.1007/s11046-020-00431-2
  9. Avasthi D, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.15709
  10. Azizirad O, 2007, CLIN NEUROL NEUROSUR, V109, P176, DOI 10.1016/j.clineuro.2006.04.010
  11. Bamberger DM, 1999, CLIN INFECT DIS, V28, P915, DOI 10.1086/517242
  12. Ranganath S, 2012, AM J MED, V125, pE1, DOI 10.1016/j.amjmed.2011.12.011
  13. Rangel-Castilla L, 2012, WORLD NEUROSURG, V77, DOI 10.1016/j.wneu.2011.06.016
  14. Recker Matthew J, 2021, Surg Neurol Int, V12, P392, DOI 10.25259/SNI_345_2021
  15. Reis F, 2016, ARQ NEURO-PSIQUIAT, V74, P514, DOI 10.1590/0004-282X20160068
  16. Riddell J, 2019, J FUNGI, V5, DOI 10.3390/jof5030070
  17. Riste M, 2019, INT J STD AIDS, V30, P1218, DOI 10.1177/0956462419869506
  18. Saccente M, 2003, SOUTH MED J, V96, P410, DOI 10.1097/01.SMJ.0000051734.53654.D0
  19. Saccente M, 2008, CURR TREAT OPTION NE, V10, P161, DOI 10.1007/s11940-008-0017-x
  20. Schestatsky P, 2006, SCAND J INFECT DIS, V38, P43, DOI 10.1080/00365540500372895
  21. Schuster JE, 2013, PEDIATR INFECT DIS J, V32, P794, DOI 10.1097/INF.0b013e31828d293e
  22. Thind GS., 2018, C53 CRITICAL CARE CA
  23. SCHWARTZ JG, 1986, NEUROSURGERY, V18, P487, DOI 10.1097/00006123-198604000-00021
  24. Seibert A, 2018, CRIT CARE MED, V46, P276, DOI 10.1097/01.ccm.0000528598.16067.93
  25. Shah N, 2022, CHEST, V162, p523A, DOI 10.1016/j.chest.2022.08.404
  26. Simms A, 2020, INT J INFECT DIS, V95, P265, DOI 10.1016/j.ijid.2020.03.072
  27. Smith JS, 2006, J NEURO-ONCOL, V79, P217, DOI 10.1007/s11060-005-9007-y
  28. Stete K, 2015, DEUT MED WOCHENSCHR, V140, P913, DOI 10.1055/s-0041-102040
  29. Sullivan AA, 1998, MED J AUSTRALIA, V169, P201, DOI 10.5694/j.1326-5377.1998.tb140222.x
  30. SUPERDOCK KR, 1994, AM J KIDNEY DIS, V23, P600, DOI 10.1016/S0272-6386(12)80386-6
  31. Tai YF, 2010, J NEUROL, V257, P1931, DOI 10.1007/s00415-010-5629-x
  32. TAN V, 1992, J NEUROL NEUROSUR PS, V55, P619, DOI 10.1136/jnnp.55.7.619
  33. Thind Guramrinder Singh, 2017, BMJ Case Rep, V2017, DOI 10.1136/bcr-2017-220476
  34. Thompson GR, 2004, DIAGN MICR INFEC DIS, V50, P33, DOI 10.1016/j.diagmicrobio.2004.04.020
  35. Threlkeld ZD, 2012, J CHILD NEUROL, V27, P532, DOI 10.1177/0883073811428780
  36. TIRABOSCHI I, 1992, EUR NEUROL, V32, P70, DOI 10.1159/000116794
  37. TYNES BS, 1963, ANN INTERN MED, V59, P615, DOI 10.7326/0003-4819-59-5-615
  38. Veeravagu A., 2013, WORLD NEUROSURG, V80, P222, DOI 10.1016/j.wneu.2012.12.016
  39. Vos MJ, 2000, NEUROLOGY, V54, P1441, DOI 10.1212/WNL.54.7.1441
  40. Vullo V, 1997, J INFECTION, V35, P83, DOI 10.1016/S0163-4453(97)91169-5
  41. WEIDENHEIM KM, 1992, HUM PATHOL, V23, P581, DOI 10.1016/0046-8177(92)90137-R
  42. Batra Vivek, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-214937
  43. Wemel AC, 2021, REV NEUROL-FRANCE, V177, P1022, DOI 10.1016/j.neurol.2020.11.014
  44. Wheat J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010245
  45. Wheat LJ, 2007, CLIN INFECT DIS, V45, P807, DOI 10.1086/521259
  46. Wheat LJ, 2006, J ANTIMICROB CHEMOTH, V57, P1235, DOI 10.1093/jac/dkl133
  47. WHEAT LJ, 1990, MEDICINE, V69, P361, DOI 10.1097/00005792-199011000-00004
  48. Wheat LJ, 2005, CLIN INFECT DIS, V40, P844, DOI 10.1086/427880
  49. Wilson MR, 2018, JAMA NEUROL, V75, P947, DOI 10.1001/jamaneurol.2018.0463
  50. Wustenberg R, 2021, INTERNIST, V62, P1231, DOI 10.1007/s00108-021-01090-1
  51. Zalduondo FM, 1996, AM J ROENTGENOL, V166, P194, DOI 10.2214/ajr.166.1.8571874
  52. Zetir M., 2017, A63 CAS REP FUNG AM
  53. Beekman R, 2018, NEUROHOSPITALIST, V8, P86, DOI 10.1177/1941874417725969
  54. Berger JR, 2010, J NEUROVIROL, V16, P472, DOI 10.3109/13550284.2010.525600
  55. Bloch KC, 2018, CLIN INFECT DIS, V66, P89, DOI 10.1093/cid/cix706
  56. Borges A S, 1997, Rev Soc Bras Med Trop, V30, P119, DOI 10.1590/S0037-86821997000200006
  57. Aguirre JPB, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010481.pub2
  58. Brahmandam S, 2019, CHEST, V156, p250A, DOI 10.1016/j.chest.2019.08.300
  59. Bui PV, 2018, CASE REP MED, V2018, DOI 10.1155/2018/3162403
  60. Calfunao DE, 2019, MEDICINA-BUENOS AIRE, V79, P287
  61. COUCH JR, 1978, NEUROLOGY, V28, P119, DOI 10.1212/WNL.28.2.119
  62. Coulter A., 2022, J ACAD CONSULT-LIAIS, V63, pS141, DOI [10.1016/j.jaclp.2022.10.061, DOI 10.1016/J.JACLP.2022.10.061]
  63. de Almeida SM, 2020, MYCOPATHOLOGIA, V185, P331, DOI 10.1007/s11046-019-00394-z
  64. Ribeiro BND, 2018, REV SOC BRAS MED TRO, V51, P722, DOI 10.1590/0037-8682-0379-2017
  65. de Moraes Junior LC., 1984, ARQ NEURO-PSIQUIAT, V42, P398, DOI [10.1590/S0004-282X1984000400014, DOI 10.1590/S0004-282X1984000400014]
  66. Dean O, 2021, J CLIN IMMUNOL, V41, P545, DOI 10.1007/s10875-020-00954-9
  67. DESAI SP, 1991, AM J NEURORADIOL, V12, P290
  68. DION FM, 1987, J COMPUT ASSIST TOMO, V11, P193, DOI 10.1097/00004728-198701000-00047
  69. DUBER RD, 1982, J AM OSTEOPATH ASSOC, V81, P554
  70. Eid AJ, 2015, CASE REP INFECT DIS, V2015, DOI 10.1155/2015/581415
  71. ENARSON DA, 1978, AM J MED, V64, P895, DOI 10.1016/0002-9343(78)90534-X
  72. Epelboin L, 2021, AM J TROP MED HYG, V105, P125, DOI 10.4269/ajtmh.20-1486
  73. Esteban I, 2016, ARCH ARGENT PEDIATR, V114, pE171, DOI 10.5546/aap.2016.e171
  74. Estrada-Bellmann I, 2016, INT J STD AIDS, V27, P75, DOI 10.1177/0956462414564608
  75. Gasparetto EL, 2005, ARQ NEURO-PSIQUIAT, V63, P689, DOI 10.1590/S0004-282X2005000400027
  76. GERBER HJ, 1966, NEW ENGL J MED, V275, P74, DOI 10.1056/NEJM196607142750204
  77. Gonzalez HH, 2019, CUREUS J MED SCIENCE, V11, DOI 10.7759/cureus.4238
  78. Groll AH, 2000, J INFECT DIS, V182, P274, DOI 10.1086/315643
  79. Hariri OR, 2015, J NEUROL SURG REP, V76, P167, DOI 10.1055/s-0035-1554932
  80. Hendrix MJ, 2021, CLIN INFECT DIS, V73, pE3727, DOI 10.1093/cid/ciaa1555
  81. Hott JS, 2003, J SPINAL DISORD TECH, V16, P212, DOI 10.1097/00024720-200304000-00016
  82. Jardim E, 1981, Arq Neuropsiquiatr, V39, P115, DOI 10.1590/S0004-282X1981000100013
  83. Jenny-Avital E, 2004, CLIN INFECT DIS, V39, P1261, DOI 10.1086/424753
  84. Klein CJ, 1999, MAYO CLIN PROC, V74, P803, DOI 10.4065/74.8.803
  85. Klumpp L, 2019, CUREUS J MED SCIENCE, V11, DOI 10.7759/cureus.6525
  86. Knapp S, 1999, EUR J CLIN MICROBIOL, V18, P658, DOI 10.1007/s100960050368
  87. Konan L, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.6984
  88. LEBOURGEOIS PA, 1979, SOUTH MED J, V72, P1624, DOI 10.1097/00007611-197912000-00046
  89. Levi GC, 2003, ARQ NEURO-PSIQUIAT, V61, P859, DOI 10.1590/S0004-282X2003000500029
  90. Livramento J A, 1993, Arq Neuropsiquiatr, V51, P80
  91. Lizarazo Jairo, 2010, Acta Neurol Colomb., V26, P120
  92. Lopez LF, 2016, MED MYCOL, V54, P677, DOI 10.1093/mmy/myw020
  93. Loughan AR, 2014, CLIN NEUROPSYCHOL, V28, P514, DOI 10.1080/13854046.2014.902107
  94. Machado L R, 1993, Arq Neuropsiquiatr, V51, P209
  95. Majeed Aneela, 2017, BMJ Case Rep, V2017, DOI 10.1136/bcr-2017-222012
  96. Makis W, 2016, BJR CASE REP, V2, DOI 10.1259/bjrcr.20150443
  97. Mawhorter SD, 2000, CLIN INFECT DIS, V30, P595, DOI 10.1086/313699
  98. McGrath M, 2022, CUREUS J MED SCIENCE, V14, DOI 10.7759/cureus.28553
  99. MCGREGOR JA, 1986, AM J OBSTET GYNECOL, V154, P925, DOI 10.1016/0002-9378(86)90488-6
  100. McKinsey DS, 2009, DIAGN MICR INFEC DIS, V63, P111, DOI 10.1016/j.diagmicrobio.2008.09.008
  101. MEDOFF G, 1987, INFECT IMMUN, V55, P1355, DOI 10.1128/IAI.55.6.1355-1358.1987
  102. Mieczkowski B., 2011, CHEST, V140, p49A, DOI [10.1378/chest.1120114, DOI 10.1378/CHEST.1120114]
  103. Mohamed A., 2016, FLUIDS BARRIERS CNS, V11
  104. Negroni R., 1995, SERODIAGN IMMUNOTHER, V7, P84, DOI [10.1016/0888-0786(95)95351-P, DOI 10.1016/0888-0786(95)95351-P]
  105. Nguyen FN, 2013, JAMA NEUROL, V70, P638, DOI 10.1001/jamaneurol.2013.1043
  106. Nicolas X, 2003, REV MED INTERNE, V24, P389, DOI 10.1016/S0248-8663(03)00073-0
  107. Nyalakonda H, 2016, AM J MED SCI, V351, P177, DOI 10.1016/j.amjms.2015.11.016
  108. O'Connor D, 2021, CHEST, V160, p325A, DOI 10.1016/j.chest.2021.07.328
  109. Onda Asako, 2018, Rinsho Shinkeigaku, V58, P241, DOI 10.5692/clinicalneurol.cn-001136
  110. Osorio N, 2014, BIOMEDICA, V34, P506, DOI [10.7705/biomedica.v34i4.2135, 10.1590/S0120-41572014000400002]
  111. Paccoud O, 2021, J TRAVEL MED, V28, DOI 10.1093/jtm/taaa167
  112. Page MJ., 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n71
  113. Peddi P, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7064
  114. Pereira GH, 2008, BRAZ J INFECT DIS, V12, P555, DOI 10.1590/S1413-86702008000600026
  115. PINEDAREYES R, 2021, AM J MED, V26
  116. PLOUFFE JF, 1980, ANN INTERN MED, V92, P189, DOI 10.7326/0003-4819-92-2-189
  117. Punsoni M, 2012, AM J CLIN PATHOL, V138, pA250, DOI 10.1093/ajcp/138.suppl1.233
  118. Queiroz-Telles F, 2017, LANCET INFECT DIS, V17, pE367, DOI 10.1016/S1473-3099(17)30306-7
  119. Radchenko C., 2012, CHEST, V142, p175A, DOI [10.1378/chest.1389355, DOI 10.1378/CHEST.1389355]
  120. Ramireddy S, 2012, MED MYCOL CASE REP, V1, P69, DOI 10.1016/j.mmcr.2012.08.002

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/47
Artigos e Materiais de Revistas Científicas - LIM/48
Artigos e Materiais de Revistas Científicas - LIM/49
Carregar mais